AstraZeneca (AZNL)

10,336.00p
   
  • Change Today:
    -1.28p
  • 52 Week High: 13,250.00p
  • 52 Week Low: 9,642.00p
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 301,231
  • Market Cap: £130,664m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
31-Mar-25 Q1 13,588.00 3,402.00 188.00¢ n/a

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 26,617.00 3,916.00 244.00¢ 40.4 0.3 +137% 280.00¢ 2.8%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,451.4 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 71.1 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.6 0.1 +242% 290.00¢ 2.0%
31-Dec-24 54,073.00 8,691.00 821.00¢ 17.1 1.3 +13% 310.00¢ 2.2%

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 57,525.60 17,965.54 667.72p 15.5 1.6 +10% 239.61p 0.0%
31-Dec-26 61,095.84 20,440.47 755.76p 13.7 1.0 +13% 252.01p 0.0%
31-Dec-27 64,592.77 22,450.27 835.26p 12.4 1.2 +10% 262.99p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 41.10 15.94 320.56 0.05

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,336.00p
Change Today -1.28p
% Change -1.22 %
52 Week High 13,250.00p
52 Week Low 9,642.00p
Volume 301,231
Shares Issued 1,264.16m
Market Cap £130,664m

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Jul-2025

Time Volume / Share Price
16:29 45 @ 10,336.00p
16:29 24 @ 10,336.00p
16:29 24 @ 10,336.00p
16:29 28 @ 10,336.00p
16:29 24 @ 10,336.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page